MALINVERNO, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 1.650
EU - Europa 858
AS - Asia 279
SA - Sud America 6
Totale 2.793
Nazione #
US - Stati Uniti d'America 1.634
IT - Italia 225
DE - Germania 157
SE - Svezia 129
IE - Irlanda 108
SG - Singapore 105
CN - Cina 93
AT - Austria 69
RU - Federazione Russa 68
GB - Regno Unito 28
HK - Hong Kong 24
CA - Canada 16
MY - Malesia 16
BE - Belgio 15
DK - Danimarca 11
UA - Ucraina 11
IN - India 10
NL - Olanda 10
FR - Francia 9
VN - Vietnam 9
FI - Finlandia 7
TR - Turchia 6
MM - Myanmar 4
AR - Argentina 3
CZ - Repubblica Ceca 3
ID - Indonesia 3
TW - Taiwan 3
BR - Brasile 2
GR - Grecia 2
KR - Corea 2
LT - Lituania 2
NO - Norvegia 2
CO - Colombia 1
EE - Estonia 1
IR - Iran 1
JP - Giappone 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
Totale 2.793
Città #
Ann Arbor 496
Chandler 167
Frankfurt am Main 145
Fairfield 131
Dublin 105
Wilmington 99
Singapore 94
Woodbridge 82
Ashburn 69
Seattle 66
Vienna 66
Milan 56
New York 55
Houston 46
Cambridge 42
Shanghai 38
Princeton 36
Santa Clara 34
Dearborn 29
Hong Kong 24
Lawrence 18
Rome 18
Penang 16
Brussels 14
Nanjing 13
Altamura 11
Jacksonville 11
Los Angeles 11
San Diego 10
London 8
Toronto 7
Boardman 6
Buffalo 6
Helsinki 6
Fremont 5
Lissone 5
Pune 5
Appiano Gentile 4
Dong Ket 4
Kocaeli 4
Udine 4
Andover 3
Bari 3
Biassono 3
Bologna 3
Brno 3
Desio 3
Dongguan 3
Edmonton 3
Falls Church 3
Garbagnate Milanese 3
Genoa 3
Hebei 3
Jakarta 3
Jinan 3
Kunming 3
Modena 3
New Taipei 3
Paris 3
Shenyang 3
Vigevano 3
Athens 2
Beijing 2
Bergamo 2
Bonndorf 2
Carate Brianza 2
Castelnuovo Scrivia 2
Catania 2
Changsha 2
Dalmine 2
Florence 2
Franklin 2
Groningen 2
Guangzhou 2
Guiyang 2
Lucera 2
Meda 2
Monza 2
Mumbai 2
Nanchang 2
New Delhi 2
Ningbo 2
Norwalk 2
Oslo 2
Ottawa 2
Padova 2
Pavia 2
Rho 2
Sacramento 2
São Paulo 2
Tianjin 2
Triggiano 2
Wuhan 2
Amsterdam 1
Ankara 1
Arnsberg 1
Avigliana 1
Belsize Park 1
Bresso 1
Busto Arsizio 1
Totale 2.197
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 419
A worldwide cross-ethnic study of quality of life in patients with PBC: Attitude or latitude? 296
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 190
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 189
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 182
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis 176
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 176
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach 175
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 165
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 161
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 149
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 106
Comprehensive review of autoantibodies in patients with hyper-IgM syndrome 92
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 86
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis 85
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 80
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 68
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 63
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 57
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 21
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 19
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 14
Totale 2.969
Categoria #
all - tutte 11.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.108


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020276 0 0 0 0 45 40 48 33 39 32 30 9
2020/2021612 12 12 102 37 37 97 61 66 43 40 60 45
2021/2022408 44 45 57 39 31 27 10 33 19 17 29 57
2022/2023653 60 196 63 70 73 56 25 31 42 9 24 4
2023/2024412 16 12 9 37 38 110 71 13 20 30 12 44
2024/2025286 45 77 66 42 56 0 0 0 0 0 0 0
Totale 2.969